HLA
CALA

Hamilton Lane Advisors’s Calithera Biosciences, Inc CALA Stock Holding History

Hamilton Lane Advisors’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-500
Closed -$71K – 62
2015
Q2 		$71K Buy
+500
New +$116K 0.03% 59

Other funds holding CALA

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Hamilton Lane Advisors's CALA Position: Q3 2015 in Review

Hamilton Lane Advisors sold out of Calithera Biosciences, Inc (CALA) in Q3 2015, closing a stake of 500 shares — an estimated $71K sold.

Hamilton Lane Advisors first reported a position in CALA in Q2 2015 and held it in 1 quarter. The position peaked at $71K in Q2 2015. 49 funds tracked by Wall St. Rank hold CALA as of Q3 2015.

  • Hamilton Lane Advisors reported no remaining Calithera Biosciences, Inc position as of Q3 2015 after selling out during the quarter.
  • Hamilton Lane Advisors sold 500 Calithera Biosciences, Inc shares in Q3 2015, an estimated $71K.
  • Hamilton Lane Advisors first reported a position in Calithera Biosciences, Inc in Q2 2015 and held it in 1 quarter.
  • Hamilton Lane Advisors's Calithera Biosciences, Inc position peaked at $71K in Q2 2015.
  • 49 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2015.

Based on Hamilton Lane Advisors's 13F filing for Q3 2015, filed 19 Oct 2015.